Gilead Sciences' IPO

Gilead Sciences raised a round of funding on January 01, 1992. Investors include Public.

Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for viral diseases, infectious diseases and cancerutilized proprietary "combinatorial…

Articles about Gilead Sciences' IPO: